Literature DB >> 35080939

Popularity of Delta-8 THC on the Internet Across US States, 2021.

Melvin D Livingston1, Andrew Walker1, Michael B Cannell1, Matthew E Rossheim1.   

Abstract

Objectives. To assess the popularity of an emergent drug, delta-8 tetrahydrocannabinol (THC), and compare interest levels between US states with or without legalized recreational cannabis. Methods. We used Google Trends to assess the growth of interest among delta-8 THC-related search terms from May 17, 2020, to May 9, 2021. We examined differences between states with or without legalized cannabis using state-level Google Trends data from February 13 to May 13, 2021, and policy data from the National Conference of State Legislatures. Results. Interest in delta-8 THC increased starting in mid-June 2020, with search volumes for delta-8 THC queries currently at 35% of the "marijuana" query. States where recreational cannabis is illegal had higher relative queries than did states with legalized recreational cannabis (52.3 vs 14.8; t = 40.9; P < .001). Conclusions. There has been rapid growth in interest in delta-8 THC. Findings between state policy contexts likely indicate delta-8 THC's role as a substitute good for delta-9 THC. Public Health Implications. Digital signals such as search volumes may point to an emergent use trend in the substance delta-8 THC. Further studies are needed to assess potential harms and correlates of delta-8 THC use. (Am J Public Health. 2022;112(2):296-299. https://doi.org/10.2105/AJPH.2021.306586).

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35080939      PMCID: PMC8802579          DOI: 10.2105/AJPH.2021.306586

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  1 in total

1.  Cannabinoid Vaping Products Present Novel Challenges for Assessment of Respiratory Health Effects.

Authors:  Charlotte A Love; Kevin D Schichlein; Phillip W Clapp; Ilona Jaspers
Journal:  Toxicol Sci       Date:  2022-06-28       Impact factor: 4.109

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.